Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Merck Group and Johnson & Johnson both invested in a $22.6m round for the autoimmune disease drug developer, six years after it was spun off from Merck Serono.

University of Michigan will supply an initial $2.75m in funding to MemryX, Ripple Science, GreenMark Biomedical, and Give and Take, and could invest as much as $20m altogether.

Johnson & Johnson, Takeda, Chong Kun Dang and Handok were among the participants in a series B round expected to advance acne and IBD drugs into the clinic.

SetSquared-affiliated health test kit supplier Forth has procured capital from investors including Development Bank of Wales, adding to a crowdfunding campaign in 2017.

Neuspera Medical has secured a $12m extension to bring its series B round to the targeted $26m close, with 6 Dimensions Capital returning from the first tranche.

Neuspera Medical has secured a $12m extension to bring its series B round to the targeted $26m close, with all investors from the first tranche returning.

Cell conversion technology developer Mogrify's founding team includes representation from the universities of Bristol and Monash, as well as Duke University - NUS Medical School.

Tencent is in line for an exit after China-based cosmetic surgery booking platform SoYoung confidentially filed to go public in the US in an offering that could raise $300m.

Robert Haché will end his tenure as vice-president of research and innovation at York University to lead Laurentian University from July.